Synapse - Works

Results (713)

PTEN loss-of-function alterations are associated with intrinsic resistance to BRAF inhibitors in metastatic melanoma

Journal Article

Catalanotti, F.; Cheng, D. T.; Shoushtari, A. N.; Johnson, D. B.; Panageas, K. S.; Momtaz, P.; Higham, C.; Won, H. H.; Harding, J. J.; Merghoub, T.; more...
JCO Precision Oncology (2017)

Fulltext@MSK | Save

The hematopoietic cell transplantation comorbidity index (HCT-CI) is not predictive of outcomes in germ CE cancer patients receiving autologous transplantation

Meeting Abstract

Greenberg, D.; Shah, G. L.; Maloy, M.; Devlin, S. M.; Giralt, S. A.; Perales, M. A.; Feldman, D. R.
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Toxicities and outcomes in the first year after ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation in adults with hematologic malignancies

Meeting Abstract

Kosuri, S.; Herrera, D. A. A.; Scordo, M.; Shah, G. L.; Devlin, S. M.; Maloy, M.; Nieves, J.; Cho, C.; Borrill, T.; Carlow, D.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Outcomes of pharmacokinetically targeted busulfan-based conditioning regimen for patients with myelodysplastic syndrome and acute myelogenous leukemia undergoing CD34 selected allogeneic hematopoietic stem cell transplantation

Meeting Abstract

Beyer, K.; Proli, A. J.; Zheng, J. T.; Bhatt, V.; Lin, A.; Papadopoulos, E. B.; Jakubowski, A. A.; Perales, M. A.; Castro-Malaspina, H.; Giralt, S. A.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Impact of busulfan exposure on transplant outcomes for patients with relapsed multiple myeloma undergoing CD34-selected allogeneic hematopoietic stem cell transplant

Meeting Abstract

Lin, A.; Drill, E.; Proli, A. J.; Beyer, K.; Bhatt, V.; Devlin, S. M.; Koehne, G.
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Prognostic factors of CLL patients undergoing reduced intensity allogeneic hematopoietic stem cell transplantation in the immunochemotherapy era

Meeting Abstract

Lahoud, O. B.; Hilden, P.; Maloy, M.; Dahi, P.; Castro-Malaspina, H.; Giralt, S. A.; Perales, M. A.; Sauter, C. S.
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Depth and timing of improvement of response for multiple myeloma patients on lenalidomide maintenance after autologous hematopoietic stem cell transplantation (Auto HCT)

Meeting Abstract

Shah, G. L.; Assal, A.; Hsu, M.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; Smith, E.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Safety and efficacy of re-immunization with inactivated vaccines in multiple myeloma patients on lenalidomide maintenance following autologous hematopoietic stem cell transplantation (auto HCT)

Meeting Abstract

Palazzo, M.; Shah, G. L.; Copelan, O.; Seier, K.; Devlin, S. M.; Hassoun, H.; Korde, N. S.; Lendvai, N.; Lesokhin, A. M.; Mailankody, S.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Post-transplant toxicities and outcomes in long-term survivors of ex-vivo CD34+ selected allogeneic hematopoietic cell transplantation

Meeting Abstract

Scordo, M.; Shah, G. L.; Kosuri, S.; Herrera, D. A.; Cho, C.; Devlin, S. M.; Maloy, M.; Nieves, J.; Borrill, T.; Carlow, D.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save

Graft-versus host disease (GVHD status and severity mediate late effects of allogeneic hematopoietic stem cell transplantation (HSCT) in a 1-year landmark analysis

Meeting Abstract

Sola, M.; Devlin, S. M.; Maloy, M.; Dierov, D.; Barker, J. N.; Castro-Malaspina, H.; Dahi, P.; Jakubowski, A. A.; Koehne, G.; Papadopoulos, E. B.; more...
Biology of Blood and Marrow Transplantation (2017)

Fulltext@MSK | Save